Both murine and clinical studies found that ASCs isolated from T2DM individuals had a more inflammatory phenotype (e.g., increased TNF gene expression) and a reduced immunosuppressive capacity (e.g., decreased TGFB expression) [[29], [30], [31], [32]]. The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.